Search by Drug Name or NDC

    NDC 00409-7338-01 Ceftriaxone Sodium 500 mg/1 Details

    Ceftriaxone Sodium 500 mg/1

    Ceftriaxone Sodium is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc. The primary component is CEFTRIAXONE SODIUM.

    Product Information

    NDC 00409-7338
    Product ID 0409-7338_c89e0cee-3419-4c53-bce1-796a1f911117
    Associated GPIs 02300090102110
    GCN Sequence Number 009166
    GCN Sequence Number Description ceftriaxone sodium VIAL 500 MG INJECTION
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 39961
    HICL Sequence Number 003996
    HICL Sequence Number Description CEFTRIAXONE SODIUM
    Brand/Generic Generic
    Proprietary Name Ceftriaxone Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ceftriaxone Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name CEFTRIAXONE SODIUM
    Labeler Name Hospira, Inc
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065169
    Listing Certified Through 2025-12-31

    Package

    NDC 00409-7338-01 (00409733801)

    NDC Package Code 0409-7338-01
    Billing NDC 00409733801
    Package 10 VIAL, SINGLE-USE in 1 CARTON (0409-7338-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-7338-11)
    Marketing Start Date 2005-05-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.97033
    Pricing Unit EA
    Effective Date 2022-05-18
    NDC Description CEFTRIAXONE 500 MG VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis